← All companies

XRAY · CIK 818479

What Dentsply Sirona Inc. told the SEC could break it.

Dentsply Sirona's disclosures center on input and manufacturing concentration. Its precious-metal dental alloys leave it exposed to gold, platinum, palladium and silver prices — it held about 17,000 troy ounces (roughly $49 million market value) on consignment — and a large number of its products are made in facilities that are the sole source of those products, with certain raw materials coming from single-source suppliers, some of which also compete with it. Its supply chain is cross-border in ways that draw in trade policy: a significant share of the dental equipment it sells in the U.S. is made in Europe (plus some China-sourced components), and tariffs were a cited driver of its 2025 gross-margin decline. It also flags about $56 million of cash trapped in Russia under that government's transfer-control measures.

4 self-disclosed vulnerabilities, pulled from its own filings — each in the company’s words, with the source. This is the risk register almost nobody reads.

In its own words

What could break it.

Commodity & input dependence

  • precious metals (gold, platinum, palladium, silver) for dental alloysmedium

    Precious-metal dental alloys expose Dentsply to gold/platinum/palladium/silver prices; it held ~17,000 troy ounces (~$49M market value) on consignment at 7.4% average annual carrying rate.

    At December 31, 2025, the Company had approximately 17,000 troy ounces of precious metal, primarily gold, platinum, palladium and silver on consignment for periods of less than one year with a market value of $49 million.

    SEC filing →As of 2026

Regulatory & policy

  • U.S. tariffs on imported dental equipment/materials (Europe, China)medium

    Tariffs were a cited driver of the 2025 gross-margin decline; a significant share of dental equipment sold in the U.S. is made in Europe (plus some China-sourced components), exposing imports to tariffs and retaliation.

    Currently, a small portion of the products, materials, and components used in our products are imported from China, and a significant share of the dental equipment that we sell in the United States is manufactured in Europe.

Sole-source dependency

  • sole-source manufacturing facilities and single-source raw materialsmedium

    A large number of Dentsply's products are made in facilities that are the sole source of those products, and certain raw materials come from single-source suppliers (some of which also compete with it) — concentrating both production and input supply.

    Although we maintain multiple manufacturing facilities, a large number of the products manufactured by us are manufactured in facilities that are the sole source of such products.

    SEC filing →As of 2026

Geographic concentration

  • Russia operations / trapped cashlow

    Russia/Ukraine were ~3% of net sales with $94M net assets; $56M of cash in Russia is available for local use but limited in its ability to be transferred out due to Russian control measures.

    The balance as of December 31, 2025 includes $ 56 million of cash and cash equivalents located in Russia which is available for use in local operations but limited in its ability to be transferred out of the country due to control measures currently in place by the Russian government.

In the MyPRIA app, this is checked against the companies you actually own.

← World Watch